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Abstract: The recent introduction of bank vole (Clethrionomys glareolus) as an additional laboratory
animal for research on prion diseases revealed an important difference when compared to the mouse and
the Syrian hamster, since bank voles show a high susceptibility to infection by brain homogenates from
a wide range of diseased species such as sheep, goats, and humans. In this context, we determined the
NMR structure of the C-terminal globular domain of the recombinant bank vole prion protein (bvPrP)
[bvPrP(121–231)] at 20 °C. bvPrP(121–231) has the same overall architecture as other mammalian PrPs,
with three ฀-helices and an antiparallel ฀-sheet, but it differs from PrP of the mouse and most other
mammalian species in that the loop connecting the second ฀-strand and helix ฀2 is precisely defined at
20 °C. This is similar to the previously described structures of elk PrP and the designed mouse PrP
(mPrP) variant mPrP[S170N,N174T](121–231), whereas Syrian hamster PrP displays a structure that is
in-between these limiting cases. Studies with the newly designed variant mPrP[S170N](121–231), which
contains the same loop sequence as bvPrP, now also showed that the single-amino-acid substitution S170N
in mPrP is sufficient for obtaining a well-defined loop, thus providing the rationale for this local structural
feature in bvPrP.
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Abbreviations: PrP, prion protein; bvPrP, bank vole PrP; ePrP, elk PrP; HSQC, 
heteronuclear single quantum coherence; mPrP, mouse PrP; mPrP[S170N](121−231), 
polypeptide segment of residues 121–231 of the variant of mPrP with Ser170 replaced by 
Asn (see Schätzl et al.45 for the numeration used); NOE, nuclear Overhauser 
enhancement; NOESY, nuclear Overhauser enhancement spectroscopy; shPrP, Syrian 
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Abstract 
The recent introduction of the bank vole (Clethrionomys glareolus) as an additional 
laboratory animal for research on prion diseases revealed an important difference when 
compared to the mouse and the Syrian hamster, since bank voles show high susceptibility 
to infection by brain homogenate from a wide range of diseased species, such as sheep, 
goat and man. In this context, we determined the NMR structure of the C-terminal globular 
domain of the recombinant bank vole prion protein (bvPrP(121−231)) at 20°C. 
bvPrP(121−231) has the same overall architecture as other mammalian PrPs, with three 
α-helices and an antiparallel β-sheet, but it differs from PrP of the mouse and most other 
mammalian species in that the loop connecting the second β-strand and the helix α2 is 
precisely defined at 20°C. This is similar to the previously described structures of elk PrP 
and the designed mouse PrP variant mPrP[S170N,N174T](121−231), whereas Syrian 
hamster PrP displays a structure that is in-between these limiting cases. Studies with the 
newly designed variant mPrP[S170N](121−231), which contains the same loop sequence 
as bvPrP, now also showed that the single-amino acid substitution S170N in mouse PrP is 
sufficient for obtaining a well-defined loop, thus providing the rationale for this local 
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Introduction 
The bank vole (Clethrionomys glareolus) has recently attracted interest due to 
unexpected features revealed by its use as a new laboratory animal for the investigation of 
prion diseases. When compared to the mouse and the Syrian hamster, bank voles are 
highly susceptible to infection by sheep and goat scrapie, and various human strains of 
transmissible spongiform encephalopathies (TSE) also show a low transmission barrier.1-3 
Responding to the ensuing interest in the three-dimensional structure of bank vole PrP 
(bvPrP), this paper describes the NMR structure of the C-terminal globular domain in the 
healthy, cellular form of bvPrP (bvPrPC) at 20°C. To support the analysis of the structure of 
bvPrP(121−231), we further solved the structure of a designed mouse PrP (mPrP) variant, 
mPrP[S170N](121−231), and pursued a detailed comparison of the two structures.  
Prion diseases, or TSEs, are a group of neurodegenerative diseases which include 
scrapie in sheep, Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform 
encephalopathy (BSE) in cattle, and chronic wasting disease (CWD) in mule deer and 
elk.4-6 Critical events in the development and propagation of TSEs include the conversion 
of the cellular prion protein, PrPC, to a protease-resistant aggregated isoform, PrPSc, which 
accumulates most pronouncedly in neurologic tissues of the affected organisms.4 While 
TSEs can be transmitted within the same species, “transmission barriers” make 
interspecies transmission inefficient, as evidenced either by complete absence of 
detectable transmission or by prolonged incubation periods prior to onset of clinical signs.7 
The occurrence of “new variant CJD” in humans in the 1990s, which was attributed to the 
prion strain identified in BSE-infected cattle in the 1980s,8-11 emphasized the critical 
importance of transmission barriers and the possibility of their breakdown for food 
management and for public health services.  
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The amino acid sequence homology between PrP of the host and the donor is the 
basic determinant of the barrier between different species,7 whereby single-amino acid 
exchanges can cause a significant change in the susceptibility to infection.7,12 It has also 
been argued that the efficiency of transmission could further be affected by variation of the 
PrPC conformations of the donor and the recipient.13 The three-dimensional structures of 
PrPC from various species have been solved by solution NMR, including humans, cattle, 
sheep and elk, and the widely used laboratory animals hamster and mouse.14-21 The global 
PrPC architecture in all mammalian species studied so far is nearly identical, with a flexibly 
extended 100-residue N-terminal tail and a 100-residue globular C-terminal domain, which 
contains three α-helices and an antiparallel β-sheet. Nonetheless, subtle local structure 
variations between different species were observed in the globular domain, in particular in 
a loop formed by the residues 165–171, which link the second β-strand and the helix α2. 
At 20°C, the β2−α2 loop is precisely defined in PrPC from elk PrP (ePrPC), but disordered 
in the NMR structures of PrPC from a variety of other species, including man, cattle, sheep 
and mouse, and is partially ordered in PrPC from Syrian hamster (shPrPC) at 30°C. This 
special structural feature in ePrP(121−231) was attributed to the nature of the amino acid 
residues in positions 170 and 174, since the three-dimensional structure of the designed 
mouse variant mPrP[S170N,N174T](121−231) also includes a precisely structured loop of 
residues 165–171 at 20°C.20 
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Cloning, expression and purification of bvPrP(121–231) and mPrP[S170N](121–231) 
The amino acid sequence of bvPrP(121−231) differs from mPrP(121–231) at only 
four positions (Figure 1). Therefore we used site-directed mutagenesis to replace these 
four residues in mPrP(121−231) in order to obtain the gene encoding bvPrPC. Similarly, we 
used site-directed mutagenesis with mPrP(121–231) to generate mPrP[S170N](121–231). 
For the NMR structure determinations of bvPrP(121–231) and mPrP[S170N](121–231), 
the uniformly 15N- and 13C,15N-labeled proteins were produced in Escherichia coli and 
purified using the standard protocol for mammalian PrPCs.17,22  
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NMR structure determination of bvPrP(121–231) and mPrP[S170N](121–231) 
Nearly complete sequence-specific backbone and amino acid side chain 
assignments were obtained for bvPrP(121–231) and mPrP[S170N](121–231), including all 
of the residues 167−171 and 175, which were not observed in mPrP(121−231)14, with Hα 
of Phe175 being the only missing backbone assignment in bvPrP(121−231). Steady-state 
15N{1H}-heteronuclear NOE data then indicated that bvPrP(121–231) and 
mPrP[S170N](121–231) form a globular domain, with positive NOE-values near 0.8 for the 
residues 125−228, and that the flanking residues 121−124 and 229−231 undergo high-
frequency motions, as evidenced by negative 15N{1H}-NOE values (data not shown). 
On the basis of the essentially complete resonance assignments, a high-quality 
structure determination for the globular domain was obtained, as documented by the 
statistics for the final ATNOS/CANDID/DYANA cycle of the structure determination (Table 
1) and the displays of the structure in Figure 2. The figure 2A shows that bvPrP(121–231) 
contains three α-helices spanning the residues 144−156, 172−194 and 200−225, and a 
two-stranded antiparallel β-sheet of residues 128−131 and 161–164. The helices α1 and 
α2 end with a 310-helical turn, and a 310-helical turn is also formed by the residues 
165−169. The side-chains are well-defined, with the ones in the hydrophobic core bounded 
by the helices α2 and α3 having mean global displacements of less than 0.6 Å (Figure 
2B). 
The structure determination of mPrP[S170N](121–231) converged with closely 
similar statistics as bvPrP(121−231) (Table 1). The two structures can be superimposed 
with an rmsd value of 1.5 Å for the backbone heavy atoms. A superposition of the two 
structures (Figure 3C) visualizes the near-identity of the two folds, where the C-terminal 
end of helix α2 is less precisely defined in mPrP[S170N](121−231).
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Local structure variations in the globular domains of bvPrP(121−231), 
mPrP(121−231) and mPrP[S170N](121−231) and possible correlations with TSE 
transmission 
Earlier experiments with bank vole PrP provided indications that the residues in 
positions 155 and 170 have an important role for the conversion of bvPrPC into bvPrPSc.2,3 
Both positions show high variation among mammalian species.23,24 In the three-
dimensional structure they are both solvent-exposed, and they are located in two well 
separated molecular regions that have previously been discussed as important structural 
epitopes for TSE transmission,14 including that the helix α1 in PrPC has been suggested to 
act as an initiation site for the structural conversion.25 The transmission barrier between 
mouse PrPC and Syrian hamster PrPSc was actually traced back to residue 155 in the helix 
α1.26 Superpositions of the three-dimensional NMR structure of bvPrP(121−231) with 
mPrP(121−231) (Figure 3A), shPrP(121−231) (Figure 3B) and the designed variant protein 
mPrP[S170N](121−231) (Figure 3C) now show that there is no significant structural 
variation near to the helix α1 among these three species. Therefore, it seems likely that 
the chemical nature of the amino acid residue in position 155 contributes to the higher TSE 
susceptibility of bank voles, rather than its impact on the local three-dimensional structure. 
The residue 170 is located in a surface epitope formed by the β2−α2 loop and parts 
of the helix α3. This epitope was previously suggested to be a recognition site in a 
mouse/human chimera PrPC for a potential chaperone, designated as “protein X”, which 
would promote the conversion of PrPC into PrPSc.27,28 Figure 3 shows that the β2−α2 loop 
is precisely defined for both bvPrP(121−231) and mPrP[S170N](121−231) at 20°C, as was 
previously also observed for ePrP(121−231) and mPrP[S170N,N174T](121−231),20 and 
that it is also quite well defined in shPrP(121−231) at 30°C.15 All the backbone amide 
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resonances of the loop residues are present in the 2D [15N,1H]-HSQC spectra of Figure 4, 
B and C, whereas they are absent in the spectrum of Figure 4A, which is the reason why 
the NMR structure of mPrP(121−231) contains a disordered β2−α2 loop.14,20 One notices 
further that the C-terminal end of helix α3 forms closer contacts with the β2−α2 loop in 
bvPrP(121−231), mPrP[S170N](121−231) and shPrP(121−231) than in mPrP(121−231) 
(Figure 3). A close approach of the helix α3 to the β2−α2 loop was also observed in 
ePrP(121−231) and mPrP[S170N,N174T](121−231).20 
Molecular dynamics calculations with the cellular form of the mouse prion protein29 
provide support for the experimental observation that the residue Ser170 has a marked 
influence on the conformational properties of the β2−α2 loop in mPrPC.  
Finally, it is striking that both bank voles and cervids carry an asparagine residue at 
position 170, which seems to be correlated either with a higher susceptibility to horizontal 
TSE transmission30, or a lower transmission barrier to inter-species transmission.31 The 
impact of the nature of the residue 170 on the conformation of the β2−α2 loop in PrPC thus 
appears to propagate to species-specific intermolecular contacts. In this way the loop 
conformation could assume a trigger function in the disease-related conversion of PrPC 
into PrPSc. To further investigate possible physiological consequences of structural 
variations in the β2−α2 loop, studies with transgenic mice expressing PrP[S170N,N174T], 
which corresponds to the β2−α2 loop sequence of ePrP,20 are pursued in a collaboration 
with the group of A. Aguzzi at the University of Zürich.  
 
Bank Vole Prion Protein Structure  Last change 17.11.2020 
 - 10 - 
Data bank accession codes 
The atomic coordinates for bvPrP(121−231) and mPrP[S170N](121−231) have 
been deposited in the Protein Data Bank (www.pdb.org, PDB ID codes 2k56 and 2k5o); 
the chemical shift lists are available at the BioMagResBank (www.bmrb.wisc.edu, 
accession numbers 15824 and 15845). 
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Figure captions  
 
Figure 1 
Amino acid sequence comparison of the C-terminal globular domain, spanning residues 
121−231, of bank vole PrP (bvPrP, Clethrionomys glareolus, GenBank: AAL57231) with 
mouse PrP (mPrP, Mus musculus, GenBank:AAA39997), Syrian hamster PrP (shPrP, 
Mesocricetus auratus, GenBank:AAA37091), human PrP (hPrP, Homo sapiens, GenBank: 
AAA60182) and elk PrP (ePrP, Cervus elaphus elaphus, GenBank: AAU93885). The 
numeration of bvPrP and the locations of the regular secondary structures in bvPrP are 
indicated at the top. The complete sequence of bank vole PrP is given. For the other 
species, only amino acids that are different from bvPrP are indicated, with dots indicating 
the presence of identical amino acids, and dashes indicating deletions. 
The mouse PrP variant mPrP[S170N](121–231) was generated from mPrP(121−231) by 
using the QuikChange® site-directed mutagenesis kit (Stratagene) according to the 
manufacturer's instructions, with the two primers 5'−CCA GTG GAT CAG TAC AAC AAC 
CAG AAC ACC−3' and 5'−GGT GTT CTG GTT GTT GTA CTG ATC CAC TGG−3'. As 
bvPrP(121−231) differs from mPrP(121−231) by only four amino acid substitutions 
(Y155N, S170N, D227E, R230S), its sequence was generated by three subsequent 
mutagenesis steps, starting from the plasmid encoding mPrP[S170N](121–231). The 
primers 5'−CGT GAA AAC ATG AAC CGC TAC CCT A−3' and 5'−T AGG GTA GCG GTT 
CAT GTT TTC ACG−3' were used for the mutagenesis Y155N, 5'−G GCC TAT TAC GAA 
GGG CGT CGT TCC−3' and 5'−GGA ACG ACG CCC TTC GTA ATA GGC C−3' for 
D227E, and 5'−GCC TAT TAC GAA GGG CGT AGC TCC TAG TAA GAA TTC GAA GCT 
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TGA−3' and 5'−TCA AGC TTC GAA TTC TTA TCA GGA ACT ACG CCC TTC GTA ATA 
GGC−3' for R230S. 
 
Figure 2 
Stereo views showing the residues 125−228 in the NMR structure of bvPrP(121−231). (A) 
Superposition of the 20 energy-minimized conformers used to represent the NMR 
structure. The N-terminal amino acid position 125 and sequence locations of the beginning 
and the end of the three α-helices are indicated. α-helices are highlighted in blue, β-
strands are green, and the disulfide bond between residues 179 and 214 is orange. (B) All-
heavy-atom presentation of the energy-minimized conformer with the lowest DYANA target 
function value. The backbone is represented by a grey spline function through the Cα 
positions. The side-chains are colored according to their global heavy atom displacements, 
D32: cyan, D < 0.6 Å; yellow, 0.6 Å < D < 1.2 Å; red, D > 1.2 Å. 
 
Figure 3 
Pairwise superpositions of the polypeptide segments 125−228 in the NMR structures of 
prion proteins that are related to the PrPs of three laboratory animals that are widely used 
in prion research. (A) bvPrP(121−231) (grey) and mPrP(121−231) (yellow). The radius of 
the cylindrical rods representing the polypeptide backbone is proportional to the mean 
global backbone displacement among the 20 energy-minimized conformers used to 
represent the NMR structures. For the residues of bvPrP(121−231) which differ from 
mPrP(121−231), red stick diagrams of the bundle of 20 conformers in Figure 2A are shown 
and identified with red lettering. (B) bvPrP(121−231) (grey) and shPrP(121−231) (green). 
Same presentation as (A), with the variable side chains in green. (C) bvPrP(121−231) 
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(grey) and mPrP[S170N](121-231) (blue). Same presentation as (A), with variable side 
chains in blue. 
 
Figure 4 
2D [15N,1H]-HSQC spectra recorded at a 1H frequency of 500 MHz and T = 20°C. (A) 
mPrP(121–231). (B) bvPrP(121–231). (C) mPrP[S170N](121–231). The peaks 
corresponding to residues 166−175 are highlighted, with blue circles identifying peaks that 
are present in all three spectra, and red circles around peaks that were not observed in 
mPrP(121−231). The Asn170 and Phe175 peaks of bvPrP(121−231) and 
mPrP[S170N](121−231) are broadened when compared to the other peaks in the same 
spectra, and therefore only weak contours are seen. 
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Table caption 
Table 1 
Input for the structure calculations and characterization of the energy-minimized NMR 
structures of bvPrP(121−231) and mPrP[S170N](121−231). 
a Except for the two top entries, the average value for the 20 energy-minimized 
conformers with the lowest residual DYANA target function values and the standard 
deviation among them are given. 
b NMR experiments were performed at 20°C with uniformly 15N- or 13C,15N-labeled protein 
samples of bvPrP(121−231), and at 25°C with mPrP[S170N](121−231). Both proteins had 
been expressed in E. coli and purified following standard procedures.17,22 The NMR 
samples contained protein concentrations of 0.4−1.0 mM in 10 mM [d4]-sodium acetate 
buffer, pH 4.5, 90% H2O/10% D2O. Standard triple resonance NMR experiments33 were 
recorded on a Bruker DRX 500 spectrometer equipped with a triply tuneable cryogenic 
probehead to obtain sequence-specific resonance assignments. Side-chain assignments 
were obtained with 3D 15N-resolved [1H,1H]-TOCSY and 3D HCCH-TOCSY spectra 
measured on a Bruker DRX 600 spectromter equipped with a triple-resonance z-gradient 
probehead. Steady-state 15N{1H}-nuclear Overhauser enhancements (NOEs) were 
measured with recovery delays and proton saturation periods of 2 and 3 sec, respectively, 
and for the reference experiment we used a 5 sec recovery period.34,35 The program 
CARA36 was used for the spectral analysis. 
3D 15N-resolved [1H,1H]-NOESY spectra were recorded at a 1H frequency of 900 MHz for 
bvPrP(121−231) and of 750 MHz for mPrP[S170N](121−231). For both proteins, two 3D 
13C-resolved [1H,1H]-NOESY spectra were collected at 750 MHz, with the 13C carrier 
frequency either in the aliphatic or the aromatic region. All NOESY data sets were 
measured with a mixing time of 60 ms. Automatic peak picking and NOE assignment was 
Bank Vole Prion Protein Structure  Last change 17.11.2020 
 - 27 - 
performed using the standalone ATNOS/CANDID program package.37,38 The final cycle of 
the structure calculation with DYANA39 was started with 100 randomized conformers; the 
20 conformers with the lowest residual target function values were energy-minimized in a 
water shell with the program OPALp40 using the AMBER force field.41 The program 
MOLMOL42 was used to analyze the results of the structure calculations and to prepare 
the drawings of the structures. Regular secondary structure boundaries were determined 
with MOLMOL, using the method of Kabsch and Sander.43 
c bb indicates the backbone atoms N, Cα, C’; ha stands for “all heavy atoms”. The 
numbers in parentheses indicate the residues for which the rmsd values were calculated. 
d As determined by PROCHECK.44 
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Figure 3 
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Table 1  
 bvPr(121−231)a mPrP[S170N](121−231)a 
NOE upper distance limitsb 1694 1567 
Dihedral angle constraints 114 116 
Residual target function value (Å2) 1.15 ± 0.40 1.39 ± 0.29 
Residual distance constraint violations   
   Number > 0.1 Å 25 ± 4 25 ± 4 
   Maximum (Å) 0.14 ± 0.01 0.14 ± 0.01 
Residual dihedral angle constraint 
violations 
  
   Number > 2.0 deg 0 ± 0 0 ± 0 
   Maximum (deg) 0.97 ± 1.32 1.35 ± 0.98 
Amber energies (kcal/mol)   
   Total −4873 ± 66 −4893 ± 114 
   Van der Waals −329 ± 14 −337 ± 17 
   Electrostatic −5467 ± 65 −5482 ± 107 
rmsd to the mean coordinates (Å)c   
   bb (125−226) 0.68 ± 0.08 0.68 ± 0.10 
   ha (125−226) 1.10 ± 0.10 1.11 ± 0.09 
Ramachandran plot statisticsd   
   Most favored regions (%) 85 85 
   Additional allowed regions (%) 14 13 
   Generously allowed regions (%) 1 2 
   Disallowed regions (%) 0 0 
 
 
 
